Delivery Order SPE2DB20D1100-SPE2DB25FE5Z6
Award Date 9/11/25
Potential Completion Date 9/12/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $35.3K delivery order to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and designates AmerisourceBergen's Conshohocken, Pennsylvania facility as the place of performance. The delivery order is a child contract action issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $6,647.56 to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on August 4, 2025, with a final delivery date of August 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,014.60 for 420 mg vials of Ontruzant on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, issued with no set-aside designation, was competitively awarded by the Defense Logistics Agency's Medical Supply Chain to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $28,115.42 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ontruzant 420 mg vials, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ontruzant is a biosimilar to Herceptin used in oncology treatments, reflecting AmerisourceBergen's role...
- The Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 150 mg vials of Ontruzant, a biosimilar medication, valued at $7,045.40. This contract was competitively awarded without a set-aside designation on September 8, 2025, with an ultimate completion date of September 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ontruzant 150 mg vials, a biosimilar to trastuzumab used in cancer treatment. This firm fixed-price delivery order, valued at $6,808.01, represents a non-competitive set-aside contract and carries an ultimate completion date of July 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ontruzant 150 mg vials, a biosimilar therapeutic product. This firm fixed-price delivery order, valued at $6,850.25, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The ultimate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,232.01, is for the supply of ONTRUZANT 420 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,562.50 firm fixed-price delivery order is for ONTRUZANT 150 MG VIALS, a medical product, with a completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ONTRUZANT 150 MG vials, with a completion date of March 6, 2024 and a potential value of $1,436.46. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and has...